Can FDA's Breakthrough Program Finally Midwife Gene Therapy?

The often-troubled field is showing promise, and the extra resources that breakthrough designation will bring to two candidates could be what gene therapy needs to move from the theoretical to the marketable.

DNA

More from Review Pathways

More from Pathways & Standards